Microbix Biosystems Inc. (TSE:MBX) Director Bo Hollas Sells 150,000 Shares

Microbix Biosystems Inc. (TSE:MBX) Director Bo Hollas sold 150,000 shares of the firm’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of C$0.49, for a total transaction of C$73,500.00.

Microbix Biosystems Stock Up 4.3 %

Microbix Biosystems stock opened at C$0.49 on Friday. The firm has a market cap of C$66.98 million, a price-to-earnings ratio of 12.25 and a beta of 0.34. The firm has a fifty day moving average price of C$0.40 and a two-hundred day moving average price of C$0.36. Microbix Biosystems Inc. has a fifty-two week low of C$0.29 and a fifty-two week high of C$0.52. The company has a debt-to-equity ratio of 22.68, a current ratio of 6.62 and a quick ratio of 5.57.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.